Latest News about MNMD
Recent news which mentions MNMD
From Benzinga
Psyched: Seattle Decriminalizes Psychedelics, Psilocybin Increases Emotions From Music, Novamind's Palliative Care Program
October 11, 2021
From Benzinga
Former Tilray CEO Joins Psychedelics Company
October 07, 2021
From Benzinga
7 Penny Stocks to Pick Up if You Have $100 to Spare
October 07, 2021
From InvestorPlace
MindMed Teams Up With Sphere Health To Identify Biomarkers Associated With Anxiety & Depression
October 05, 2021
Tickers
MNMD
From Benzinga
From Benzinga
From Benzinga
6 Psychedelic Stocks With Buy Rating: Why Are They Good Investments?
October 01, 2021
From Benzinga
Four Stocks Disrupting Mental Health To Keep An Eye On At Benzinga's Healthcare Conference
September 30, 2021
From Benzinga
Digital Therapeutics And The Future Of Psychedelic Medicine
September 29, 2021
Tickers
MNMD
From Benzinga
From InvestorPlace
Psyched: Delic Buys 10 Ketamine Clinics For $10M, Atai Launches Ibogaine Human Trials, Small Pharma Concludes Phase 1 DMT Study
September 27, 2021
From Benzinga
7 of the Best Penny Stocks to Buy Coming Into Year-End
September 21, 2021
Tags
NYSEAMERICAN:EMAN,NASDAQ:BOXL,NASDAQ:XELA,NASDAQ:MNMD,NASDAQ:BIOC,NASDAQ:EBON,OTCMKTS:UURAF,NYSE:DGX
EBON
UURAF
From InvestorPlace
Compass: Psychedelics Unicorn Expands Portfolio Beyond Psilocybin Into Psychedelics 2.0
September 15, 2021
From Benzinga
Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry?
September 09, 2021
From Benzinga
7 Penny Stocks Waiting on The FDA for Rocket Fuel
September 09, 2021
Tags
VTVT
Market News
NASDAQ:ATOS,NASDAQ:CLVS,NASDAQ:MNMD,NASDAQ:PMCB,NASDAQ:SESN,NASDAQ:VBIV,NASDAQ:VTVT
From InvestorPlace
Psyched: Field Trip Gets $20 Price Target, DEA Seeks To Increase Psilocybin Production Limits, Synthesis Closes $7.25M Series A
September 07, 2021
From Benzinga
EXCLUSIVE: Kevin O'Leary Unpacks Deal Flow, Investments, Perspectives On Disruptive Innovation
August 31, 2021
From Benzinga
From Benzinga
MindMed Teams Up With Forian To Improve Real-World Evidence Data To Help Psychiatric Patients
August 24, 2021
From Benzinga
Cramer Weighs In On RealReal, Affirm Holdings And More
August 17, 2021
From Benzinga
Push the Boundaries of DMT Therapy with Mind Medicine
August 16, 2021
Tickers
MNMD
From InvestorPlace
MindMed Reports Q2 Earnings With Net Loss of $36M And Cash Balance Of $157M To Continue With Its Clinical Pipeline
August 16, 2021
Tickers
MNMD
From Benzinga
10 Penny Stocks to Buy to Create a $500 Portfolio
August 11, 2021
From InvestorPlace
No Matter How the Pandemic Rolls, Mind Medicine Will Prevail
August 11, 2021
Tickers
MNMD
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2021
August 05, 2021
From Benzinga
From InvestorPlace
Psyched: Field Trip Uplists To Nasdaq, MindMed To Study DMT, Atai Launches New Subsidiary, AOC's Psychedelics Amendment Rejected
August 02, 2021
From Benzinga
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.